Ratings by Jones Trading (Catherine Novack)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/7/2026 | Crinetics | CRNX | Downgrade | Hold (Buy) |
42.03 (83.86) |
99.52% | Details | |
| 6/8/2026 | Spruce Biosciences, Inc. | SPRB | New Coverage | Buy (N/A) |
50.43 (43.54) |
-13.66% | Details | |
| 5/8/2026 | Korro Bio Inc. | KRRO | Upgrade | Buy (Hold) |
12.89 (12.25) |
-4.97% | Details | |
| 4/16/2026 | Precision BioSciences Inc. | DTIL | New Coverage | Buy (N/A) |
7.66 (7.87) |
2.74% | Details | |
| 3/26/2026 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2026 | iBio, Inc. | IBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2026 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | iBio, Inc. | IBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2026 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | iBio, Inc. | IBIO | New Coverage | Buy (N/A) |
2.82 (1.38) |
-51.06% | Details | |
| 2/24/2026 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | Larimar Therapeutics | LRMR | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2026 | Korro Bio Inc. | KRRO | Maintain | Hold (N/A) |
|
Details | ||
| 1/28/2026 | Korro Bio Inc. | KRRO | Maintain | Hold (N/A) |
|
Details | ||
| 1/5/2026 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2025 | Septerna Inc | SEPN | New Coverage | Buy (N/A) |
29.47 (33.40) |
13.34% | Details | |
| 12/15/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2025 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2025 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2025 | Korro Bio Inc. | KRRO | Downgrade | Hold (Buy) |
31.42 (12.89) |
-58.98% | Details | |
| 11/12/2025 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2025 | Larimar Therapeutics | LRMR | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2025 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2025 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2025 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2025 | Larimar Therapeutics | LRMR | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2025 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | Dyne Therapeutics | DYN | New Coverage | Buy (N/A) |
10.63 (23.74) |
123.33% | Details | |
| 6/24/2025 | Capricor Therapeutics | CAPR | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2025 | Larimar Therapeutics | LRMR | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2025 | Femasys Inc. | FEMY | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2025 | Regulus Therapeutics | RGLS | Downgrade | Hold (Buy) |
3.37 (8.16) |
142.14% | Details | |
| 4/15/2025 | Rallybio Corp. | RLYB | Downgrade | Hold (Buy) |
0.25 (16.42) |
6468% | Details | |
| 3/25/2025 | Larimar Therapeutics | LRMR | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2025 | Palvella Therapeutics | PVLA | New Coverage | Buy (N/A) |
28.14 (157.24) |
458.78% | Details | |
| 3/10/2025 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | ProQR Therapeutics N.V. | PRQR | New Coverage | Buy (N/A) |
2.12 (1.70) |
-19.81% | Details | |
| 12/5/2024 | Capricor Therapeutics | CAPR | Maintain | Buy (Buy) |
|
Details | ||
| 11/29/2024 | Regulus Therapeutics | RGLS | Maintain | Buy (Buy) |
|
Details | ||
| 11/18/2024 | Korro Bio Inc. | KRRO | New Coverage | Buy (N/A) |
49.70 (12.25) |
-75.35% | Details | |
| 11/18/2024 | Capricor Therapeutics | CAPR | New Coverage | Buy (N/A) |
18.49 (19.44) |
5.14% | Details | |
| 10/31/2024 | Equillium | EQ | Downgrade | Hold (Buy) |
1.38 (2.59) |
87.68% | Details | |
| 10/16/2024 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2024 | Kezer Life Sciences | KZR | Maintain | Hold (N/A) |
|
Details | ||
| 9/24/2024 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2024 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2024 | Larimar Therapeutics | LRMR | New Coverage | Buy (N/A) |
7.89 (3.70) |
-53.11% | Details | |
| 9/9/2024 | Rezolute | RZLT | Maintain | Buy (Buy) |
|
Details | ||
| 9/3/2024 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2024 | WAVE Life Sciences | WVE | New Coverage | Buy (N/A) |
5.98 (5.82) |
-2.68% | Details | |
| 8/8/2024 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2024 | CalciMedica | CALC | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | Regulus Therapeutics | RGLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2024 | Rallybio Corp. | RLYB | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2024 | Purple Biotech Ltd. | PPBT | Maintain | Buy (N/A) |
|
Details | ||
| 5/30/2024 | Regulus Therapeutics | RGLS | New Coverage | Buy (N/A) |
2.13 (8.16) |
283.1% | Details | |
| 5/16/2024 | Dare Bioscience | DARE | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | CalciMedica | CALC | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2024 | Rezolute | RZLT | New Coverage | Buy (N/A) |
3.40 (4.61) |
35.59% | Details | |
| 4/17/2024 | Rezolute | RZLT | New Coverage | Buy (N/A) |
3.40 (3.40) |
0% | Details | |
| 3/28/2024 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2024 | Femasys Inc. | FEMY | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2024 | Crinetics | CRNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2024 | Rallybio Corp. | RLYB | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2024 | CalciMedica | CALC | New Coverage | Buy (N/A) |
4.85 (0.74) |
-84.74% | Details | |
| 10/16/2023 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2023 | Kezer Life Sciences | KZR | Downgrade | Hold (Buy) |
1.04 (7.29) |
600.96% | Details | |
| 9/26/2023 | Femasys Inc. | FEMY | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Decibel Therapeutics Inc | DBTX | Downgrade | Hold (Buy) |
2.79 (4.91) |
75.99% | Details | |
| 7/21/2023 | Purple Biotech Ltd. | PPBT | New Coverage | Buy (N/A) |
1.25 (1.47) |
17.6% | Details | |
| 3/10/2023 | Omega Therapeutics | OMGA | New Coverage | Buy (N/A) |
6.90 (0.14) |
-97.97% | Details | |
| 12/1/2022 | Dare Bioscience | DARE | New Coverage | Buy (N/A) |
0.90 (1.96) |
117.78% | Details | |
| 4/4/2022 | Aldeyra Therapeutics | ALDX | New Coverage | Buy (N/A) |
4.71 (1.69) |
-64.12% | Details | |
| 3/7/2022 | Rallybio Corp. | RLYB | New Coverage | Buy (N/A) |
9.89 (16.42) |
66.03% | Details | |
| 12/2/2021 | Decibel Therapeutics Inc | DBTX | New Coverage | Buy (N/A) |
6.77 (4.91) |
-27.47% | Details | |
| 11/15/2021 | Catalyst Biosciences | CBIO | Downgrade | Hold (Buy) |
2.94 (14.75) |
401.7% | Details | |
| 11/12/2021 | Catalyst Biosciences | CBIO | Downgrade | Hold (Buy) |
2.94 (14.75) |
401.7% | Details | |
| 10/4/2021 | Amryt | AMYT | New Coverage | Buy (N/A) |
12.19 (14.70) |
20.59% | Details | |
| 5/3/2021 | Crinetics | CRNX | New Coverage | Buy (N/A) |
17.31 (42.03) |
142.81% | Details |
